Herpes Simplex Virus Type 1 (HSV-1) UL38 Capsid Protein: A Promising Target Against Viral Infection

This publication has 21 references indexed in Scilit:

• STING agonists as antiviral agents
  FEBS Letters, 2025
• Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents
  Nature Communications, 2025
• Viral evasion of cGAS-STING pathway: opportunities for intervention
  Trends in Pharmacological Sciences, 2025
• Targeting STING antagonism in HSV-1: A peptide-based strategy to restore antiviral immunity and suppress viral pathogenesis
  Cell Reports Medicine, 2025
• Herpes simplex virus and drug resistance—comprehensive update on resistance mutations and implications for clinical management: a narrative review
  Clinical Microbiology and Infection, 2025
• Herpes simplex virus 1 encodes a STING antagonist that can be therapeutically targeted
  Cell Reports Medicine, 2025
• New frontiers in the cGAS-STING intracellular DNA-sensing pathway
  Immunity, 2024
• Therapeutic peptides: current applications and future directions
  Signal Transduction and Targeted Therapy, 2022
• Detection of herpes simplex virus infection in mucosal and cutaneous ulcers of the suspected patients by real-time PCR
  International Journal of Infectious Diseases, 2012
• Antiretroviral therapy and management of HIV infection
  The Lancet, 2010